[go: up one dir, main page]

EP2782552B1 - Nagellackzusammensetzung - Google Patents

Nagellackzusammensetzung Download PDF

Info

Publication number
EP2782552B1
EP2782552B1 EP12791844.9A EP12791844A EP2782552B1 EP 2782552 B1 EP2782552 B1 EP 2782552B1 EP 12791844 A EP12791844 A EP 12791844A EP 2782552 B1 EP2782552 B1 EP 2782552B1
Authority
EP
European Patent Office
Prior art keywords
composition
thiol
nail
coating composition
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP12791844.9A
Other languages
English (en)
French (fr)
Other versions
EP2782552A2 (de
EP2782552B8 (de
Inventor
Hugh COOKE
Colin John BRUNTON
Maria DINCHEVA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemence Ltd
Original Assignee
Chemence Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemence Ltd filed Critical Chemence Ltd
Publication of EP2782552A2 publication Critical patent/EP2782552A2/de
Publication of EP2782552B1 publication Critical patent/EP2782552B1/de
Application granted granted Critical
Publication of EP2782552B8 publication Critical patent/EP2782552B8/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10—Esters
    • C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • C08F222/1025—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate of aromatic dialcohols
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D4/00—Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; Coating compositions, based on monomers of macromolecular compounds of groups C09D183/00 - C09D183/16
    • C09D4/06—Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups C09D159/00 - C09D187/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Definitions

  • This invention relates to novel nail coating compositions, to packages including the novel nail coating compositions, to methods of applying the nail coating composition of the present invention and to a use of an additive compound to improve the properties of the nail coating composition of the present invention.
  • the invention relates to novel nail coating compositions having improved chip resistance, good adhesion to the nail, a high gloss finish and a short dry-to-touch time.
  • nail coatings are based on formulations that comprise a solvent and a film former (mentioned as (1) above). Although there has been some variation with the choice of solvent in the nail coating composition, the general components of modern nail coatings are very similar to those invented 80 years ago. There are only a small number of nail coatings manufacturers throughout the World, which might explain the stagnation in this particular field. Thus, modern nail coatings are essentially solvent borne films containing nitrocellulose, pigments, dyes and other optimizing substances.
  • the solvents most favoured in conventional nail coating compositions are polar organic ester and alcohol solvents for example butyl acetate, ethyl acetate and isopropanol.
  • Toluene is still used in some countries, but because of its carcinogenicity, toluene is being phased out.
  • These particular solvents have been chosen largely because of their ability to evaporate quickly and therefore allow the nail coating composition to dry quickly.
  • solvent which is evaporated when the nail coating composition is applied. This portion of the nail coating composition is therefore wasted. Additionally, the presence of the solvent in the nail coating composition leads to unnecessary weight in the transportation of the product to its point of sale.
  • UK Patent Application No. GB 2 452 566 is an earlier filed patent application of the same applicant.
  • This document discloses a nail coating composition comprising a radiation curable nail coating substance and at least one dye and/or pigment dissolved and/or dispersed in the composition to impart a colour to the coating.
  • the composition disclosed in this document does not use a volatile solvent in the composition, but instead uses an oil to disperse the pigment.
  • the single example provided in this document is a radiation curable substance that comprises a thiol compound in an amount of about 2% w/w of the composition.
  • composition disclosed in the example of GB 2 452 566 exhibits an excellent thermal stability, resistance to premature cross-linking (i.e. cross-linking when in the bottle) and polymerisation and excellent shelf life properties, this product is rendered not commercially viable on account of its poor durability.
  • this document does not address important issue that the nail composition does not have an adequate level of chip resistance.
  • the adhesion of the coating produced by the composition of GB 2 452 566 is unsatisfactory in that the coating may become detached from the nail too quickly.
  • a nail coating composition is a high chip resistance once cured.
  • methacrylate compounds are the slowest to react with the thiol component because of their relatively poor reactivity.
  • UV curable nail coatings utilise a multi-step / multi-product system.
  • many nail coating systems require the application of several products in sequence to achieve the desired chip resistance.
  • a UV curable undercoat treatment may first be applied to the nail to achieve a high degree of adhesion to the nail itself.
  • a UV curable colour coating is applied in one or two layers to decorate the nail in a particular colour.
  • a UV curable top coat of extremely glossy finish may be applied.
  • the various products required for this system make the whole process a costly and laborious exercise. Further, mild abrasion may be required to remove the various UV cured nail coatings.
  • UV curable coatings are often applied alone and then cured as in (3) above.
  • UV curable compositions are inhibited from curing by air at the top surface of the coating. This means that to achieve a very high gloss and non tacky surface finish an additional subsequent process involving wiping away traces of incompletely cured material with a solvent soaked cloth or pad is also required.
  • US2003/0073753 discloses a composition for actinic radiation curable nail coatings and artificial nail tips comprising a BISGMA based urethane resin, an additional polymer, a photoinitiator and having a viscosity of greater than approximately 80,000 cps.
  • a single composition having 11.11% w/w of a specific tri-functional thiol in the composition. It is disclosed that the composition including the tri-functional thiol is "more tack-free" and that the coating is less brittle than when the composition does not include the thiol.
  • the composition of this document does not demonstrate the desired properties that the coating is a dry-to-touch coating, i.e.
  • compositions having this level of thiol do not demonstrate the desired properties of an entirely tack-free, dry to touch composition, see Example 15 which includes a composition having 11.0% of a trifunctional thiol.
  • the compositions of the present invention demonstrate the desirable properties of being entirely tack-free and dry-to-touch without the need to wipe off the tacky outer layer that has not cured and therefore represent a novel and inventive improvement over these prior art compositions.
  • US2007/0010617 discloses an aqueous dispersion for nail enamel.
  • the aqueous dispersion includes a copolymer which is manufactured using an acrylate monomer and another radical-polymerisation unsaturated monomer in the presence of a thiol component.
  • the actual nail enamel does not itself include a thiol component; the thiol component is utilised in the manufacture of the copolymer, and the copolymer is part of the aqueous dispersion for nail enamel.
  • the copolymer that is produced is in the form of an aqueous disersion which is then mixed with pigments and monomers to provide an aqueous nail enamel composition.
  • the copolymer that is used in the aqueous dispersion for nail enamel can be manufactured using a thiol component having a formula of (HS-CH 2 -CH 2 -COO) n -R, wherein n can be 1 to 4, the examples only recite the manufacture of the copolymer using mono-functional thiol components; bis-, tris- and tetra-functional thiol components are not recited in the examples of US2007/0010617 .
  • the purpose of the thiol component is to chain-terminate the polymer with the thiol group and thus to control the emulsion polymerisation of the methacrylated monomers and this is mentioned in paragraph [0056].
  • the single thiol group will attach itself to the end of the chain by donating a hydrogen atom from the SH group and stop chain propagation at that end. Accordingly, the thiol component that is utilised in the manufacture of the copolymer can only be a mono-functional thiol as higher functional thiol components would be too reactive with the other acrylate monomer and radical-polymerisation unsaturated monomer components. Furthermore, there are always 10 parts or less thiol in the compositions of US2007/0010617 , which means that the thiol component will always completely react with the methacrylate and unsaturated monomer components in the composition. Accordingly, the copolymer manufactured will never include a free -SH group for further reaction in the aqueous dispersion of the nail enamel.
  • US 5,922,334 discloses a nail composition having a thiol component as a chain transfer agent.
  • the chain transfer agent is used at a level from about 0.01 to 5 weight percent based on the total weight of the monomer.
  • chain transfer agents include 3-mercaptopropionic acid and t-dodecyl mercaptan, i.e. thiol components having a single -SH group. There is no disclosure of thiol components having two or more -SH groups.
  • US 3,896,014 discloses_the use of an allyl oligomer in conjunction with a polythiol in a UV curable nail coating.
  • the compositions in this document are based solely on polyenes, thiols and photioinitiaotors (i.e. the compositions do not include a monomer component). This means that the cured coatings will cross link very strongly and will be very difficult, if not impossible, to remove by a solvent soak off process if applied directly to the nail.
  • the authors of US 3,896,014 recommend the use of a tie coat layer with water swellable properties so that the complete nail coating can be removed in warm water. Thus, in order to obtain removal in warm water it is essential to apply the water soluble base coat.
  • the desired properties from a nail coating are:
  • the present invention achieves one or more, e.g. all, of the above listed aims.
  • a nail coating composition comprising: a radiation curable component comprising an acrylate-terminated oligomer in combination with at least one acrylate monomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a compound containing two or more SH groups, and wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% of the nail coating composition.
  • a nail coating composition comprising: a radiation curable component comprising an allyl-terminated oligomer in combination with at least one acrylate monomer and/or at least one acrylate-terminated oligomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a compound containing two or more SH groups, and wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% of the nail coating composition.
  • a nail coating composition comprising: a radiation curable component comprising an acrylate-terminated oligomer in combination with at least one acrylate monomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a thiol compound containing two or more SH groups, and wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% of the nail coating composition and when the thiol consists of a tetra or higher functional thiol it is present as at least 10% of the nail coating composition.
  • a nail coating composition comprising: a radiation curable component comprising an allyl-terminated oligomer in combination with at least one acrylate monomer and/or at least one acrylate-terminated oligomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a thiol compound containing two or more SH groups, and wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% of the nail coating composition and when the thiol consists of a tetra or higher functional thiol it is present as at least 10% of the nail coating composition.
  • a radiation curable nail coating composition which cures to directly form a dry to touch nail coating.
  • a method of applying the nail composition of the present invention to a nail comprising: contacting the nail with the composition; and exposing the composition to radiation to cure the composition.
  • a method of applying the nail composition of the present invention to a nail comprising: directly contacting the nail with the composition; and exposing the composition to radiation to cure the composition.
  • a method of applying the nail composition of the present invention to a nail comprising: contacting the nail with the composition; and exposing the composition to radiation to cure the composition; wherein the method does not include a step of wiping off an uncured outer layer of the nail composition.
  • a thiol compound in a nail composition of the invention for improving the adhesion of the nail coating composition to the nail.
  • a thiol compound in a nail composition of the invention for increasing the chip resistance of the nail coating composition.
  • a thiol compound for imparting dry-to-touch characteristics to a nail coating composition comprising a radiation curable component comprising an acrylate-terminated oligomer in combination with at least one acrylate monomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a compound containing two or more SH groups, wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% w/w of the nail coating composition and wherein when the thiol is a tetra or higher functional thiol it is present as at least 10% w/w of the nail coating composition.
  • a thiol compound for imparting dry-to-touch characteristics to a nail coating composition comprising: a radiation curable component comprising an allyl-terminated oligomer in combination with at least one acrylate monomer and/or at least one acrylate-terminated oligomer; and a thiol component present in an amount of from about 5% to about 90% w/w of the nail coating composition, wherein the thiol component comprises a compound containing two or more SH groups, wherein when the thiol component consists of a bis and/or tris functional thiol it is present as at least 15% w/w of the nail coating composition and wherein when the thiol is a tetra or higher functional thiol it is present as at least 10% w/w of the nail coating composition.
  • nail includes both natural nails and also artificial and false nails.
  • the nail composition may include a number of components.
  • the sum of the percentage contents of the components of the nail composition equals 100%.
  • the composition may be described as comprising from about 5% to about 90% w/w of a thiol and from about 5% to about 90% w/w of an acrylic acid-terminated oligomer.
  • the composition may have 50% w/w of a thiol compound.
  • the remaining 50% w/w of the composition may be the acrylic acid-terminated oligomer and photoinitiator.
  • the nail coating composition may include one or more additional components selected from photoinitiator(s), thickening agent(s), free-radical stabiliser(s), colorant(s), chelator(s) and adhesion promoter(s) amongst others. Unless otherwise stated, all percentages herein refer to percentage weight based on the total weight of the composition concerned.
  • carbon atom ranges disclosed in this specification are defined by reference to the end points of the range. However, all intermediate carbon atom numbers of any specifically mentioned range are also disclosed.
  • C 1-10 means a moiety having 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms
  • C 1-4 means a moiety having 1, 2, 3 or 4 carbon atoms
  • C 3-6 means a moiety having 3, 4, 5 or 6 carbon atoms.
  • each independently selected from the group comprising or “each independently selected from the group consisting of” means that each of the listed 'R' groups may be selected independently of the other 'R' groups (here the term 'R' group refers to any group R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 etc. Therefore, each 'R' group may be the same or different from each other R group.
  • R 1 and R 2 are each independently selected from the group consisting of: H and a substitutent
  • R 1 is H and R 2 is a substituent
  • R 2 is H and R 1 is a substituent
  • R 1 is H and R 2 is H and (4)
  • R 1 is a substituent and R 2 is a substituent.
  • R 1 and R 2 may be the same substituents or may be different substitutents since they are each "independently selected" R groups. The same applies to other pairs of 'R' groups.
  • substituted means a non-hydrogen moiety, for example hydroxy, carboxy, carboxamido, imino, alkanoyl, cyano, cyanomethyl, nitro, amino, halogen (e.g. fluoro, chloro or bromo), C 1-6 haloalkyl (e.g. trifluoromethyl), C 1-6 alkoxy (e.g. methoxy, ethoxy or propoxy), C 1-6 haloalkoxy (e.g. trifluoromethoxy), hydrocarbyl or hydrocarbyloxy group.
  • the non-hydrogen moiety does not detrimentally interfere with the curing process or with the stability of the composition.
  • substituted may be each independently unsubstituted or substituted (wherever chemically possible) with from 1 to 5 substituents selected from the group consisting of: hydroxy, carboxy, carboxamido, imino, alkanoyl, cyano, cyanomethyl, nitro, amino, halogen (e.g. fluoro, chloro or bromo), C 1-6 alkyl (e.g. methyl, ethyl or propyl), C 1-6 haloalkyl (e.g. trifluoromethyl), C 1-6 alkoxy (e.g. methoxy, ethoxy or propoxy), C 1-6 haloalkoxy (e.g.
  • C 3-6 cycloalkyl e.g. cyclohexyl
  • aryl e.g. phenyl
  • aryl-C 1-6 alkyl e.g. benzyl
  • C 1-6 alkyl aryl e.g. trifluoromethoxy
  • C 3-6 cycloalkyl e.g. cyclohexyl
  • aryl e.g. phenyl
  • aryl-C 1-6 alkyl e.g. benzyl
  • C 1-6 alkyl aryl e.g. benzyl
  • Hydrocarbyl and hydrocarbyloxy groups disclosed herein may have, for example, from 1 to 14, e.g. 1, 2, 3, 4, 5 or 6 carbon atoms.
  • hydrocarbyl groups include those consisting of one or a combination of moieties selected from: alkyl, cycloalkyl, alkenyl, cycloalkenyl and aryl (e.g. phenyl), as is the case of phenylalkyl groups.
  • hydrocarbyl may be a non-hydrogen group selected from the group consisting of: alkyl (e.g. C 1-6 alkyl); alkenyl (e.g. C 2-6 alkenyl); aryl (e.g. phenyl); cycloalkyl (e.g. C 3-6 cycloalkyl); cycloalkenyl (e.g.
  • C 4-6 cycloalkenyl alkyl alkenyl (e.g. C 1-6 alkyl C 2-6 alkenyl), alkenyl alkyl (e.g. C 2-6 alkenyl C 1-6 alkyl), aryl alkyl (e.g. phenyl C 1-6 alkyl, for example benzyl); aryl alkyl (e.g. C 1-6 alkyl phenyl), alkyl cycloalkyl (e.g. C 1-6 alkyl C 4-6 cycloalkyl), cycloalkyl alkyl (e.g. C 3-6 cycloalkyl C 1-6 alkyl); cycloalkenyl alkyl (e.g. C 1-6 alkyl C 2-6 alkenyl), alkenyl alkyl (e.g. C 2-6 alkenyl C 1-6 alkyl), aryl alkyl (e.g. phenyl C 1-6 alkyl, for example benz
  • C 4-6 cycloalkenyl C 1-6 alkyl e.g. C 1-6 alkyl C 3-6 cycloalkyl
  • alkyl cycloalkyl e.g. C 1-6 alkyl C 3-6 cycloalkyl.
  • the above mentioned C 1-6 alkyl may be optionally interrupted by -O-, -S- or -NR-.
  • the term "package" includes a bottle for nail polish.
  • the means for applying the nail coating composition to a nail may include a nail polish applicator.
  • the nail polish applicator may extend from a removable cap of the bottle and be configured to enter the bottle when the cap is engaged with the bottle.
  • the bottle may include a neck which is configured to engage the removable cap.
  • the neck is typically a hollow cylinder or tube.
  • the neck of the bottle and the removable cap may each be threaded such that the removable cap can be engaged and disengaged with the bottle by a twisting action.
  • the nail polish applicator generally extends from an interior of the removable cap.
  • the cap itself can be used as a handle which can be gripped when applying the nail polish to the nail.
  • the applicator includes a brush that the user dips into the nail polish to apply the same onto the user's nails.
  • the brush typically includes a plurality of bristles extending axially or substantially axially from a shaft of the applicator and held onto the shaft of the applicator by a collar or adhesive. Suitable materials for the bristles of the brush include lacquered or unlacquered nylon.
  • the applicator includes a dipstick which includes a sponge tip that the user may use to dip and apply the nail polish to the intended nail.
  • the sponge tip may be wedge-shaped tip to allow more precision in application of the nail polish due to the relatively sharp edge of the wedge and thus provide finer lines than a brush.
  • the applicator is typically configured so that the end of the applicator, i.e. the end of the applicator distal to the removable cap, is in contact with the interior surface of the base of the nail polish container.
  • the volume of the nail polish bottle may be from about 1 ml to about 50 ml. In an embodiment, the nail polish bottle has a volume of about 3 ml, about 4 ml, about 7 ml, about 10 ml or about 15 ml.
  • the nail coating composition may include one or more additional components selected from photoinitiator(s), thickening agent(s), free-radical stabiliser(s), colorant(s), chelator(s) and adhesion promoter(s) amongst others. Further details of these components are given below.
  • the viscosity of the nail composition is from about 500 to about 2000 cPs.
  • the viscosity of the nail composition is from about 750 to about 1500 cPs.
  • the viscosity of the nail composition is about 1000 cPs. All viscosity values herein refer to the viscosity measured at 25°C. The skilled person would be able to determine the necessary ratio of the components of the invention to achieve the desired viscosity. For example, adding a higher proportion of oligomer relative to monomer will increase the viscosity.
  • the nail composition does not contain an aqueous phase.
  • the thiol component may include a mixture of more than one (e.g. two or three) different thiol compounds.
  • the thiol component may consist of or consist essentially of a single thiol compound.
  • the thiol component may include that thiol compound as the sole thiol compound or as one of a plurality of thiol compounds.
  • thiol includes compounds having from 2 to 10 -SH group(s). Each -SH group is bonded to a carbon atom. In other words, the thiol compounds have from 2 to 10 -C-S-H moiety(ies).
  • the thiol compound may be either simple or complex organic compounds having from 2 to 10 -SH group(s) at any position in the molecule.
  • the thiol compound may be either simple or complex organic compounds having from 2 to 10 -SH group(s) that are pendant or terminally positioned. It will be recalled that the term 2 to 10 means 2, 3, 4, 5, 6, 7, 8, 9 or 10.
  • the thiol compounds have, for example 2, 3, 4, 5, 6 or 7 -C-S-H moieties.
  • the carbon atom(s) to which the -SH group(s) is/are bonded form(s) part of an alkylenyl group, in particular a -(CH 2 ) n - group, where the value of the integer n is not critical to the invention, but may be 1, 2, 3, 4, 5 or 6 for example.
  • the alkylenyl group of the thiol component may include one or more substituent group(s) as defined herein.
  • substituent group(s) as defined herein.
  • the number of -SH group(s) present in the thiol compound is subject to the number of carbon atoms in the thiol compound (i.e. chemically impossible compounds are not included within the definition of thiol compounds).
  • the thiol compound has a molecular weight of from about 100 to about 10,000 Da. In an embodiment, the thiol compound has a molecular weight of less than about 900Da and preferably less than about 700 Da.
  • the thiol compound may have a molecular weight of about 200 ⁇ 50 Da, about 250 ⁇ 50 Da, about 300 ⁇ 50 Da, about 350 ⁇ 50 Da, about 400 ⁇ 50 Da, about 450 ⁇ 50 Da, about 500 ⁇ 50 Da, about 550 ⁇ 50 Da, about 600 ⁇ 50 Da, about 650 ⁇ 50 Da or about 700 ⁇ 50 Da.
  • the thiol compound has from 2 to 10 -SH groups, i.e. 2, 3, 4, 5, 6, 7, 8, 9 or 10 such groups. In an embodiment, the thiol compound has from 2 to 5 -SH groups. In a preferred embodiment, the thiol compound has from 2 to 4 -SH groups. In further preferred embodiment, the thiol compound has 3 or 4 -SH groups.
  • the thiol compound is present in the composition of the invention in an amount of no more than about 60% w/w; no more than about 50% w/w; no more than about 40% w/w; or no more than about 35% w/w. In an embodiment, the thiol compound is present in the composition of the invention in an amount of no more than about 30%; no more than about 25% w/w; no more than about 20% w/w. In an embodiment, the thiol compound is present in the composition of the invention in an amount of from about 10% to about 80% w/w; about 10% to about 70% w/w; about 10% to about 60% w/w; about 10% to about 50% w/w.
  • the thiol compound may be present in an amount of from about 10% to about 30% w/w of the composition. In an embodiment, the thiol compound is present in the composition of the invention in an amount of from about 10% to about 15% w/w. In an embodiment, the thiol compound is present in the composition of the invention in an amount of from about 15% to about 20% w/w. In an embodiment, the thiol compound is present in the composition of the invention in an amount of from about 20% to about 25% w/w. In an embodiment, the thiol compound is present in the composition of the invention in an amount of from about 25% to about 30% w/w. For example, the thiol compound may be present in the composition of the invention in an amount of about 10%, about 11%, about 12%, about 13%, about 14% or about 15% w/w or more.
  • thiol has four or more -C-S-H moieties.
  • bis or tris functional it is meant that the thiol has two or three -C-S-H moieties.
  • the thiol component consists of or consists essentially of a mixture of more than one (e.g. two or three) different thiol compounds.
  • the thiol component may include the following mixture of tri and tetra thiol components: % Tetra thiol % Tri thiol 10 0 8 3 6 6 4 8 2 11 0 15
  • the thiol compound has a general structure: wherein
  • k 0.
  • m is an integer of from 1 to 5, preferably from 1 to 3, e.g. 1, 2 or 3.
  • n is an integer of from 1 to 5, preferably from 1 to 3, e.g. 1, 2 or 3.
  • R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of: H, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, hydrocarbyl and hydrocarbyloxy.
  • R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of: H, C 1-6 alkyl, C 2-6 alkenyl, phenyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 1-6 alkyl C 2-6 alkenyl, C 2-6 alkenyl C 1-6 alkyl, phenyl C 1-6 alkyl, C 1-6 alkyl phenyl, C 1-6 alkyl C 4-6 cycloalkyl, C 3-6 cycloalkyl C 1-6 alkyl, C 4-6 cycloalkenyl C 1-6 alkyl and C 1-6 alkyl C 3-6 cycloalkyl.
  • R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of: H and C 1-6 alkyl.
  • R 5 is selected from the group consisting of: H and -CR 6a R 6b R 6c , wherein R 6a , R 6b and R 6c are each independently selected from the group consisting of: H, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, hydrocarbyl, hydrocarbyloxy and wherein R 1 , R 2 , R 3 , R 4 , m and n are as defined above.
  • R 5 is -CR 6a R 6b R 6c , wherein R 6a , R 6b and R 6c are each independently selected from the group consisting of: H, C 1-6 alkyl and wherein R 1 , R 2 , R 3 , R 4 , m and n are as defined above.
  • R 6a is
  • the thiol compound has a general structure: wherein R 1 , R 2 , R 3 , R 4 , R 6b , R 6c , m and n are as defined above.
  • R 6b is H.
  • R 6b is
  • R 6c is H.
  • R 6c is
  • R 6c is C 1-6 alkyl, e.g. methyl, ethyl or propyl, preferably ethyl.
  • R 6b is H and R 6c is H.
  • R 6b is and R 6c is C 1-6 alkyl, e.g. methyl, ethyl or propyl, preferably ethyl.
  • R 6b is and R 6c is
  • R 5 is -CR 6a R 6b R 6c ; each of R 6a , R 6b and R 6c is each R 1 is selected from the group consisting of: H and C 1-6 alkyl; each R 2 is H; each R 3 is H; each R 4 is H; each m is 2; and each n is 1.
  • R 5 is -CR 6a R 6b R 6c ; each of R 6a and R 6b is R 6c is C 1-6 alkyl; each R 1 is selected from the group consisting of: H and C 1-6 alkyl; each R 2 is H; each R 3 is H; each R 4 is H; each m is 2; and each n is 1.
  • the thiol compound has a structure:
  • the thiol compound is an ester of mercaptopropionic acid or mercaptobutyric acid.
  • the thiol compound is pentaerythritol-4-mercaptopropionate or trimethylolpropane trimercaptopropionate.
  • the thiol compound is:
  • the thiol compound is:
  • the thiol compound is:
  • the thiol compound is:
  • radiation curable component includes compositions that are capable of curing under exposure to radiation.
  • the radiation curable components are UV radiation curable components.
  • the general constituents and their proportions of a suitable composition will be known to a person skilled in the art.
  • Curing includes the toughening or hardening of a material by cross-linking of polymer chains and, in the case of a radiation curable component, occurs as a result of the presence of chemical additives (such as photoinitiators) and exposure to radiation, e.g. UV radiation.
  • Suitable radiation curable components include a degree of unsaturation, e.g. at least one ethylenic bond.
  • the radiation curable component includes an ethylenic bond, it is this bond which is able to react (i.e. cross-link) with other materials in the composition, such as the thiol component.
  • Examples of compounds having ethylenic unsaturation and being able to react with the thiol component include compounds having a vinyl ether, allyl ether, propenyl ether, allyl triazine, allyl ioscyanurate, alkene, acrylate, unsaturated ester, maleimide, methacrylate, acrylonitrile, styrene, diene or N-vinyl amide moiety, or a combination thereof.
  • the reaction between an ethylenic bond and the thiol component is described below.
  • the reaction (i.e. cross-linking) between the different materials in the radiation curable composition results in curing of the composition.
  • a radiation curable composition will include an acrylate or methacrylate component.
  • acrylate includes methacrylate and both terms include reference to the acids as well as the esters.
  • the acrylate e.g. methacrylate component
  • the acrylate-terminated oligomer i.e. a short chain of monomers having an acrylate, e.g. methacrylate terminus.
  • oligomer a short chain of monomers having an acrylate, e.g. methacrylate terminus.
  • the skilled person is familiar with the term "oligomer and will also readily be able to identify suitable acrylate-terminated oligomers. Further details of this component are given below.
  • the oligomer portion of the acrylate-terminated oligomer typically includes an epoxy or a urethane backbone, although other acrylate-terminated oligomers may also be used.
  • the radiation curable composition may include an allyl component.
  • a radiation curable composition will include acrylic acid ester monomers.
  • acrylic acid ester monomers The skilled person will also readily be able to identify suitable acrylic acid ester monomers. Further details of this component are given below.
  • a radiation curable composition may include an allyl terminated monomer component.
  • acrylate-terminated oligomer component includes an oligomer which terminates with an acrylate group at at least one end.
  • the oligomer component may include a mixture of more than one (e.g. two or three) different oligomers.
  • the oligomer component may include a single oligomer.
  • the oligomer component may include that oligomer component as the sole oligomer component or as one of a plurality of oligomer components.
  • the term "acrylate-terminated oligomer component” includes an oligomer which has one or more pendent acrylate groups.
  • acrylate includes reference to moieties having an alpha-beta unsaturated carboxyl group, i.e. moieties that contain a vinyl group that is directly attached to a carbonyl carbon.
  • the term “acrylate” thus includes moieties having the structure: wherein the R groups in the above structure each independently represent H or a substituent. Optionally, the R groups each independently represent H or a C 1-10 alkyl group.
  • oligomer includes compounds having a few monomer units, e.g. dimers, trimers and tetramers etc of monomers.
  • An oligomer can, however, include more monomer units than this.
  • an oligomer may include from 5, 6, 7, 8, 9 or 10 monomer units or more, e.g. up to 100 monomer units.
  • Oligomers can, however, include more than 100 monomer units.
  • oligomers are manufactured from monomers that have been subjected to a finite degree of polymerization.
  • the oligomer component has a molecular weight of from about 100 to about 20,000 Da. In an embodiment, the oligomer component has a molecular weight of from about 100 to about 5,000 Da. For example, the oligomer component may have a molecular weight of from about 100 to about 2,000 Da. The oligomer component may therefore have a molecular weight of about 500 ⁇ 100, about 600 ⁇ 100, about 700 ⁇ 100, about 800 ⁇ 100, about 900 ⁇ 100, about 1000 ⁇ 100, about 1100 ⁇ 100, about 1200 ⁇ 100, about 1300 ⁇ 100, about 1400 ⁇ 100 or about 1500 ⁇ 100 Da.
  • the oligomer component and its relative amount are selected such that the desired properties of the eventual nail composition (e.g. an end viscosity of 500 to 200 cPs) are achieved.
  • the oligomer component may include a relatively small amount (in quantity) of an oligomer having a high viscosity.
  • the oligomer component may include a relatively large amount (in quantity) of an oligomer having a low viscosity.
  • the oligomer component may therefore include a small amount of a low viscosity component and a large amount of a high viscosity component or vice versa.
  • the oligomer component has a viscosity, when measured at 25°C, of about 2000 to about 150000 cPs. In an embodiment, the oligomer component has a viscosity, when measured at 25°C, of about 3000 to about 10000 cPs. In an embodiment, the oligomer component has a viscosity, when measured at 25°C, of about 3500 to about 9000 cPs, e.g. about 4000 ⁇ 500, about 4500 ⁇ 500, about 5000 ⁇ 500, or about 5500 ⁇ 500. In an embodiment, the oligomer component has a viscosity, when measured at 25°C, of about 10000 to about 20000 cPs, e.g. 10000 ⁇ 1000, 11000 ⁇ 1000, 12000 ⁇ 1000, 13000 ⁇ 1000, 14000 ⁇ 1000, 15000 ⁇ 1000 or 16000 ⁇ 1000 cPs.
  • the oligomer component of the acrylate-terminated oligomer can include an oligomer selected from the group consisting of: epoxy oligomers, aliphatic and aromatic urethane oligomers, polyether and polyester oligomers and acrylic oligomers or a combination thereof.
  • the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 5% to about 80% w/w; 5% to about 70% w/w; about 5% to about 60% w/w; about 5% to about 50% w/w; about 5% to about 40% w/w; about 5% to about 30% w/w; or about 5% to about 20% w/w.
  • the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 10% to about 60% w/w.
  • the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 10% to about 20% w/w.
  • the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 20% to about 30% w/w. In an embodiment, the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 30% to about 40% w/w. In an embodiment, the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 40% to about 50% w/w. In an embodiment, the acrylate-terminated oligomer component is present in the composition of the invention in an amount of from about 50% to about 60% w/w.
  • the acrylate-terminated oligomer component may be present in the composition of the invention in an amount of about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19% or about 20% w/w or more.
  • the oligomer component is selected from the group consisting of: Genomer 4622® (an aromatic urethane acrylate oligomer), Polyester 03-849®, Genomer 4302® (an isocyanurate oligomer), Genomer 2253® (a modified epoxy acrylate oligomer), Genomer 4590/PP® (an aliphatic urethane acrylate oligomer), Genomer 2263® (an epoxy acrylate oligomer), Genomer 2259® (a modified epoxy acrylate oligomer), Genomer 3414® (a polyether acrylate oligomer), Genomer 2280® (a modified epoxy acrylate oligomer), Genomer 4312® (an aliphatic polyester urethane acrylate), Genomer 4316® (an aliphatic urethane acrylate oligomer), Genomer 4215® (an aliphatic urethane acrylate oligomer), UA00-0022® (an aliphatic urethane oligomer
  • the oligomer component is selected from the group consisting of: Genomer 3414® (a modified polyether acrylate oligomer), Genomer 03-956® (an aliphatic urethane dimethacrylate oligomer), Genomer 2280® (a modified bisphenol A epoxy diacrylate oligomer), Genomer 2281® (a modified bisphenol A epoxy diacrylate oligomer), Genomer 4425® (an aliphatic urethane acrylate in GPTA), Genomer 09-293® (an aliphatic urethane acrylate oligomer), Photomer 6210® (an aliphatic urethane oligomer), Ebecryl 3703® (an epoxy urethane acrylate oligomer) and Ebecryl 270® (an aliphatic urethane acrylate oligomer) and combinations thereof.
  • Genomer 3414® a modified polyether acrylate oligomer
  • Genomer 03-956® an aliphatic urethane
  • Genomer® oligomers are available from Rahn®; the Photomer® oligomers are available from IGM Resins® and the Ebecryl® oligomers are available from Cytex®. Details of some of the properties of a number of these oligomers are provided in the "description" column in the examples below.
  • the oligomer component may comprise more than one (e.g. two or three) oligomers.
  • the oligomer component may comprise a mixture of Genomer 03-956® and Photomer 6210®; Genomer 2280® and Genomer 03-956®; Genomer 03-956® and Genomer 09-293®; and Ebecryl 3703® and Genomer 03-956®.
  • compositions containing an oligomer component comprising or consisting of a liquid material which may undergo a cross-linking or polymerisation reaction to become a solid.
  • allyl-terminated oligomer component includes an oligomer which terminates with term an allyl group at least one end.
  • allyl-terminated oligomer component includes an oligomer which has one or more pendent allyl groups.
  • the oligomer component may include a mixture of more than one (e.g. two or three) different oligomers.
  • the oligomer component may include a single oligomer.
  • the oligomer component may include that oligomer component as the sole oligomer component or as one of a plurality of oligomer components.
  • allyl includes moieties having the structure: wherein the R groups in the above structure each independently represent H or a substituent. Optionally, the R groups each independently represent H or a C 1-10 alkyl group.
  • the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 5% to about 80% w/w; 5% to about 70% w/w; about 5% to about 60% w/w; about 5% to about 50% w/w; about 5% to about 40% w/w; about 5% to about 30% w/w; or about 5% to about 20% w/w.
  • the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 10% to about 60% w/w.
  • the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 10% to about 20% w/w.
  • the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 20% to about 30% w/w. In an embodiment, the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 30% to about 40% w/w. In an embodiment, the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 40% to about 50% w/w. In an embodiment, the allyl-terminated oligomer component is present in the composition of the invention in an amount of from about 50% to about 60% w/w.
  • the allyl-terminated oligomer component may be present in the composition of the invention in an amount of about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19% or about 20% w/w or more.
  • suitable allyl-terminated components include:
  • the allyl-terminated component comprises a reaction product of with toluene di-isocyanate, i.e. referred to hereinafter as "oligomer A".
  • acrylic acid ester monomer includes compounds having an alpha-beta unsaturated carboxyl group, i.e. compounds that contain a vinyl group that is directly attached to a carbonyl carbon.
  • the acrylic acid ester monomer component may include a mixture of more than one (e.g. two or three) different acrylic acid ester monomers.
  • the acrylic acid ester monomer component may include a single acrylic acid ester monomer.
  • the acrylic acid ester monomer component may include that monomer as the sole monomer or as one of a plurality of monomers.
  • the term "acrylic acid ester monomer” thus includes compounds having the structure:
  • the acrylic acid ester monomer component has a molecular weight of from about 50, e.g. about 72 to about 1000 Da.
  • the acrylic acid ester monomer includes from 1 to 10 alpha-beta unsaturated carboxyl group(s).
  • the number of alpha-beta unsaturated carboxyl groups will affect the amount of cross-linking that occurs in the final composition when the composition is cured. The more alpha-beta unsaturated carboxyl groups the acrylic acid ester monomer has, the higher the degree of cross-linking.
  • the acrylic acid ester monomer includes 1, 2, 3, 4, 5 or 6 alpha-beta unsaturated carboxyl groups.
  • acrylate monomers and resins modifies the cross linking and allows soak off of the cured nail polish to be achieved. This is desirable as the alternative to soaking off the nail polish is to remove it by abrasion and chipping, which can be detrimental to the nail itself.
  • p is 0 and R 12 is H. In an embodiment, p is an integer of from 1 to 5, preferably from 1 to 4, e.g. 1, 2 or 3.
  • R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected at each occurrence from the group consisting of: H, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, hydrocarbyl and hydrocarbyloxy.
  • R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected at each occurrence from the group consisting of: H, C 1-6 alkyl, C 2-6 alkenyl, phenyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 1-6 alkyl C 2-6 alkenyl, C 2-6 alkenyl C 1-6 alkyl, phenyl C 1-6 alkyl, C 1-6 alkyl phenyl, C 1-6 alkyl C 4-6 cycloalkyl, C 3-6 cycloalkyl C 1-6 alkyl, C 4-6 cycloalkenyl C 1-6 alkyl and C 1-6 alkyl C 3-6 cycloalkyl.
  • R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected at each occurrence from the group consisting of: H and C 1-6 alkyl (e.g. methyl).
  • R 7 and R 8 are each H.
  • R 9 is selected from the group consisting of: H and C 1-6 alkyl (e.g. methyl).
  • R 10 and R 11 are each independently selected at each occurrence from the group consisting of: H and C 1-6 alkyl (e.g. methyl).
  • R 10 and R 11 are each H.
  • R 10 and R 11 together with the atom to which they are bonded form a 3-6 membered cycloalkyl group. In an embodiment, R 10 and R 11 together with the atom to which they are bonded form a cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl group. In an embodiment, R 10 and R 11 together with the atom to which they are bonded form a bi- or tri-cyclic cycloalkyl group, e.g. an isobornyl group.
  • R 12 is selected from the group consisting of: H, -OR 13 and-CR 12a R 12b R 12c ; wherein R 12a , R 12b and R 12c are each independently selected from the group consisting of: H, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, hydrocarbyl, hydrocarbyloxy and wherein R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected from the group consisting of: H and a substituent and each p is independently an integer of from 1 to 5; and R 13 is selected from the group consisting of: H and a substituent.
  • R 12 is -OH.
  • R 12 is -OR 13 and R 13 is a C 1-6 alkyl group.
  • R 12 is H.
  • R 12 is -CR 12a R 12b R 12c ; wherein R 12a , R 12b and R 12c are each independently selected from the group consisting of: H, C 1-6 alkyl, and wherein each R 7 , R 8 , R 9 , R 10 and R 11 is independently selected from the group consisting of: H and a substituent and each p is independently an integer of from 1 to 5.
  • R 12 is -CR 12a R 12b R 12c ; wherein R 12a , R 12b and R 12c are each independently each R 7 is H; each R 8 is H; each R 9 is selected from the group consisting of: H and C 1-6 alkyl; each R 10 is H; each R 11 is H; and each p is 1.
  • R 12 is -CR 12a R 12b R 12c ; wherein R 12a and R 12b are each independently
  • R 12c is C 1-6 alkyl; each R 7 is H; each R 8 is H; each R 9 is selected from the group consisting of: H and C 1-6 alkyl; each R 10 is H; each R 11 is H; and each p is 1.
  • R 12 is -CR 12a R 12b R 12c ; wherein R 12a and R 12b are each independently R 12c is wherein each R 7 , R 8 , R 9 , R 10 and R 11 is independently selected from the group consisting of: H and a substituent and each p is independently an integer of from 1 to 5.
  • R 12c is ethyl
  • R 12 is -OR 13 .
  • R 13 is: wherein R 14 and R 15 are each independently selected at each occurrence from the group consisting of: H and C 1-6 alkyl (e.g. methyl); q is an integer of from 1 to 5; and R 7 , R 8 , R 9 , R 10 , R 11 and p are as defined above.
  • R 13 is: wherein R 16 is C 1-6 alkyl, e.g. methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl or t-butyl.
  • the acrylic acid monomer includes compounds having the structure: wherein R 7 , R 8 , R 9 , R 10 and R 11 are each independently selected from the group consisting of: H and a substituent.
  • the acrylic acid ester monomer component is a monofunctional monomer for example hydroxypropyl methacrylate.
  • the acrylic acid ester monomer component is a difunctional monomer for example propoxylated neopentyl glycol diacrylate (Ebeccryl 145).
  • the acrylic acid ester monomer component is a trifunctional monomer for example trimethylolpropane triacrylate.
  • the acrylic acid ester monomer component is a tetrafunctional monomer for example dipentaerythritol tetraacrlyate.
  • the acrylic acid ester monomer component is butane-1,4-diol diacrylate.
  • the acrylic acid ester monomer component is hexane-1,6-diol diacrylate.
  • the acrylic acid ester monomer component is 2-hydroxyethyl 2-methylprop-2-enoate.
  • the acrylic acid ester monomer component is isobornyl methacrylate.
  • the acrylic acid ester monomer component is 2-((acryloyloxy)methyl)-2-ethylpropane-1,3-diyl diacrylate.
  • the acrylic acid ester monomer component is 2-ethyl-2-((methacryloyloxy)methyl)propane-1,3-diyl bis(2-methylacrylate).
  • the acrylic acid ester monomer component is 2-ethoxyethyl acrylate.
  • the acrylic acid ester monomer component is bisphenol -A-dimethacrylate.
  • the acrylic acid ester monomer component is ((2,2-dimethylpropane-1,3-diyl)bis(oxy))bis(propane-2,1-diyl) diacrylate.
  • the acrylic acid ester monomer component is methacrylic acid.
  • the acrylic acid ester monomer component is (2-[[3-[(1-oxoallyl)oxy]-2,2-bis[[(1-oxoallyl)oxy]methyl]propoxy]methyl]-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate).
  • the acrylic acid ester monomer component is 2-[[(butylamino)carbonyl]oxy]ethyl acrylate.
  • the acrylic acid ester monomer component is ethyl methacrylate.
  • the acrylic acid ester monomer component is present in the composition of the invention in an amount of up to about 90% w/w e.g. from about 10% to about 90% w/w.
  • the acrylic acid ester monomer component may be present in the composition in an amount of from about 10% to about 80% w/w; about 10% to about 70%; about 10% to about 60%; about 20% to about 70% w/w; about 20% to about 60% w/w; about 25% to about 55% w/w; about 25% to about 50% w/w; about 30% to about 45% w/w; or about 35% to about 45% w/w.
  • the acrylic acid ester monomer component is present in the composition of the invention in an amount of from about 10% to about 20%; about 20% to about 30%; about 30% to about 40%; about 40% to about 50%; or about 50% to about 60%.
  • the acrylic acid ester monomer component may be present in the composition of the invention in an amount of about 35%, about 36%, about 37%, about 38%, about 39%, about 40%, about 41%, about 42%, about 43%, about 44% or about 45% w/w or more.
  • allyl monomer component includes a compounds having an allyl group.
  • allyl monomer component includes a compound which has one or more pendent allyl groups.
  • the allyl monomer component may include a mixture of more than one (e.g. two or three) different allyl monomers.
  • the allyl monomer component may include a single allyl monomer.
  • the allyl monomer component may include that monomer as the sole monomer or as one of a plurality of monomers.
  • allyl monomer component includes moieties having the structure: wherein the R groups in the above structure each independently represent H or a substituent. Optionally, the R groups each independently represent H or a C 1-10 alkyl group.
  • the allyl monomer component is present in the composition of the invention in an amount of from about 10% to about 80% w/w; about 10% to about 70%; about 10% to about 60%; about 10% to about 50% w/w; about 10% to about 40% w/w; about 10% to about 30% w/w; or about 10% to about 20% w/w.
  • the allyl monomer component may be present in the composition of the invention in an amount of about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19% or about 20% w/w or more.
  • suitable allyl monomer components include:
  • the nail coating composition may include one or more additional components selected from photoinitiators, thickening agents, free-radical stabilisers, colorants, chelators and adhesion promoters. Further details of these components are given below.
  • the nail coating composition does not include a surfactant component.
  • the nail coating composition does not include sorbitan sesquioleate, sorbitan dioleate, sorbitan trioleate, pentaerythritol dioleate or pentaerythritol trioleate.
  • photoinitiator includes compounds that decompose free radicals when exposed to light. Therefore, photoinitiators form a free radical when exposed to light.
  • the composition may include more than one photoinitiator (e.g. two, three or four photoinitiators). In an embodiment, the composition includes a single photoinitiator. Thus, when a particular photoinitiator is recited below, the nail composition may include that photoinitiator as the sole photoinitiator or as one of a plurality of photoinitiators.
  • any photoinitiator compatible with the other components of the composition may be employed in the composition of the present invention.
  • Suitable photoinitiators can be selected from either hydrogen abstracting or the free radical forming groups.
  • the photoinitiators utilised in the present invention absorb light in the 200 - 450 nm region.
  • the photoinitiator is a UVA activated photoinitiator.
  • the photoinitiator is a UVB activated photoinitiator.
  • the photoinitiator is a UVC activated photoinitiator.
  • the photoinitiator is a UW activated photoinitiator. The skilled person is able to match the photoinitiator with the particular activation wavelength.
  • the photoinitiator is selected from the group consisting of: Irgacure 369 (2-benzyl-2 (dimethylamino)-1-[4-(4-morpholinyl) phenyl]-1-butanone), Genocure BDMM (2-benzyl-2 (dimethylamino)-1-[4-(4-morpholinyl) phenyl]-1-butanone), Irgacure 819 (phosphine oxide, phenyl bis (2,4,6-trimethyl benzoyl)), Lucirin BAPO (phenyl-bis-(2,4,6-trimethylbenzoyl) phosphine oxide, Genocure TPO (phosphine oxide, phenyl bis (2,4,6-trimethyl benzoyl)), Genocure LTM (a liquid photoinitiator blend), Lucirin TPO-L (ethyl-2,4,6-trimethylbenzoylphenylphosphinate), Genocure QC (
  • the photoinitiator is 2,2-dimethoxy-1,2 diphenylethan-1 one (known as Irgacure 651).
  • the photoinitiator is 2,4,6 trimethylbenzoylphenyl-phosphineoxide (known as Genocure TPO).
  • the photoinitiator is 1-hydroxycyclohexyl phenyl ketone (known as Irgracure 184) and also known as (1-hydroxycyclohexyl)(phenyl)methanone.
  • the photoinitiator is oligo [2-hydroxy-2-methyl-1-(4-(1-methylvinyl)phenyl)] propanone (Ezacure One).
  • the photoinitiator is bis(2,4,6-trimethylbenzoyl)-phenylphosphineoxide (Irgacure 819).
  • the photoinitiator is methylbenzoylformate (Genocure MBF).
  • the photoinitiator is present in the composition of the invention in an amount of from about 0.5% to about 20% w/w; about 0.5% to about 10% w/w; about 0.5% to about 5% w/w; or about 0.5% to about 3% w/w. In an embodiment, the photoinitiator is present in the composition of the invention in an amount of from about 4% to about 10% w/w; about 4% to about 9% w/w; about 4% to about 8% w/w; about 4% to about 7% w/w; about 4% to about 6% w/w; or about 4% to about 5% w/w.
  • the photoinitiator may be present in the composition of the invention in an amount of about 0.5%, about 0.75%, about 1.0%, about 1.25%, about 1.5%, about 1.75%, about 2.0%, about 2.25%, about 2.5%, about 2.75% or about 3.0% w/w.
  • the composition of the present invention further comprises a thickening agent.
  • the composition may include more than one thickening agent (e.g. two, three or four thickening agents).
  • the composition includes a single thickening agent.
  • the nail composition may include that thickening agent as the sole thickening agent or as one of a plurality of thickening agents.
  • the thickening agent is a fumed silica nanoparticle having a diameter of from about 5 nm to about 30 nm.
  • the nanoparticles can be obtained from a company called Aerosil®. Examples of suitable nanoparticles includes: Aerosil R202® (14 nm), Aerosil R812® (7 nm), Aerosil 2000 (12nm) and Aerosil R 974® (12 nm).
  • the thickening agent is a polymer of the acrylic acid ester monomer component.
  • the thickening agent is Avalure 315®, which is described by the manufacturers, Lubrizol®, as an acrylic copolymer for cosmetics having a specific gravity of 1.1 - 1.2, a viscosity of 10 - 200 cPs (15% solids in NH 4 OH solution) and a particle size of 60 - 100 (% through 6 mesh) according to the data sheet dated March 2007.
  • the thickening agent is present in an amount of up to 10% w/w of the composition. It may be present in an amount of at least 1% w/w or the composition. In an embodiment the thickening agent is present in an amount of up to 7.5% w/w of the composition. For example, the thickening agent may be present in an amount of from about 3% to about 6% w/w of the composition. In an embodiment the polymers are present in an amount of up to 5% w/w of the composition. In an embodiment the polymers are present in an amount of up to 2.5% w/w of the composition.
  • the purpose of the polymer component is to adjust the viscosity of the eventual composition.
  • the polymer can be used to substitute a portion of the oligomer portion.
  • the composition may include no polymer, an amount of monomer and an amount of oligomer. If it is desired to reduce the amount of oligomer, then the amount of monomer can be increased and a polymer can be introduced in order to tune the viscosity of the resulting composition.
  • the composition of the present invention further comprises a free-radical stabiliser.
  • a free-radical stabiliser may be added to the composition in an amount of up to about 2% w/w of the composition.
  • the free-radical stabiliser may be added to the composition in an amount of about 0.5%, about 1.0%, about 1.5% or about 2.0% w/w of the composition.
  • the composition may include more than one free-radical stabiliser (e.g. two, three or four free-radical stabilisers).
  • the composition includes a single free-radical stabiliser.
  • the nail composition may include that free-radical stabiliser as the sole free-radical stabiliser or as one of a plurality of free-radical stabilisers.
  • the free-radical stabiliser is selected from the group consisting of: hydroquinone, butyl hydroxytoluene, methylphenol, triphenylphosphite and Florstab UV-8 ®, which is described by the manufacturer, Kromachem®, as a blend of epoxy acrylate oligomer, polyester acrylate, plasticiser and stabiliser.
  • An amount of free-radical stabiliser may already be included in the raw materials of the present invention.
  • a free-radical stabiliser may be added to the composition.
  • the composition of the present invention is a clear and colourless nail composition. This may be applied to a bare nail to make the nail attractive and shiny.
  • the composition of the present invention further comprises a mixture for example a dispersion of a colorant and an organic liquid.
  • organic liquid may be used interchangeably with the term “carrier” or “solvent”.
  • the nail composition is used to alter the colour and appearance of the nail.
  • the composition of comprises a colorant and an organic liquid, and, taken together, the colorant and the organic liquid amount to up to about 10% w/w of the composition; up to about 7.5% w/w of the composition; up to about 5% w/w of the composition; or up to about 2.5% w/w of the composition.
  • the colorant is present in an amount of from about 20% to about 80% of combined colorant and organic liquid.
  • the colorant is a pigment.
  • the pigment is in particulate form.
  • the composition may include more than one colorant or dispersion thereof (e.g. two, three or four colorants or dispersions thereof).
  • the composition includes a single colorant or dispersion thereof.
  • the nail composition may include that colorant or dispersions thereof as the sole colorant or dispersion thereof or as one of a plurality of colorants or dispersions thereof.
  • the pigment is selected from the group consisting of: Organic Red D&C Ca Lake Cl Number 15850 - 5% (COD 8001), D&C Red 6 Ba Lake Cl No 15850 (COD 8002); Black Iron Oxide Cl No 77499 (COD 8004); FD&C Blue 1 Al Lake Cl No 42090 (COD 8007); Titanium Dioxide Cl No 77891 - 0.7% (COD 8008); FD&C Yellow 6 Al Lake Cl No 15985 (COD 8010).
  • the colorant is a photostable dye.
  • the organic liquid is a volatile solvent, e.g. a polar organic ester or alcohol solvent such as, for example, butyl acetate, ethyl acetate and isopropanol.
  • a volatile solvent e.g. a polar organic ester or alcohol solvent such as, for example, butyl acetate, ethyl acetate and isopropanol.
  • the organic liquid is not a volatile solvent.
  • the organic liquid is an oil.
  • the composition need not include volatile solvents which are generally regarded as not being environmentally friendly.
  • the organic liquid may also participate in the cross-linking reaction. This is because many oils include unsaturated bonds, e.g. carbon double bonds.
  • the oil comprises or is an ethylenically unsaturated oil.
  • the oil may be or comprise a fish or vegetable oil.
  • the oil may therefore comprise a mixture of fatty acid glycerides, e.g. a mixture comprising at least one ethylenically unsaturated fatty acid compound.
  • the thiol compound of the composition is able to react with unsaturated bonds.
  • the oil, when unsaturated is covalently incorporated into the final cross-linked structure.
  • the oil is selected from the group consisting of: castor oil, dehydrated castor oil, cotton seed oil, fish oil, linseed oil, menhaden oil, oiticaca oil, palm kernel oil, perilla oil, safflower oil, sardine oil, soybean oil and tung oil.
  • the composition further comprises up to 2% w/w of a chelator. In an embodiment, the composition comprises up to 1% w/w of a chelator. In an embodiment, the composition comprises up to 0.1% w/w of a chelator. In an embodiment, the composition comprises up from about 0.01 to about 0.1% w/w of a chelator.
  • a chelator is particularly important when the composition comprises particular colorants or pigments. For example, many pigments include a relatively high metal content. Certain metals, e.g. Cu and Fe, are known to trigger free-radical polymerisation. Thus, the presence of a chelating compound can 'trap' the metal ions and prevent any undesired free-radical polymerisation that may otherwise have been caused by the presence of the metal in the pigment or colorant.
  • the composition may include more than one chelator (e.g. two, three or four chelators). In an embodiment, the composition includes a single chelator. Thus, when a particular chelator is recited below, the nail composition may include that chelator as the sole chelator or as one of a plurality of chelators.
  • the chelator is ethylene diamine tetraacetic acid (EDTA). In an embodiment, the chelator is EDTA in the form of the sodium salt.
  • EDTA ethylene diamine tetraacetic acid
  • the chelator is 1-Hydroxy Ethylidene-1,1-Diphosphonic Acid (HEDP).
  • the composition further comprises an adhesion promoter.
  • the adhesion promoter may be in an amount of up to about 10% w/w of the composition.
  • the composition may further comprise up to about 9%, up to about 8%, up to about 7%, up to about 6%, up to about 5%, up to about 4%, up to about 3% or up to about 2% w/w of an adhesion promoter.
  • the adhesion promoter may be in an amount of at least about 0.5% w/w e.g. at least 1% w/w as in the case of from about 1% to about 8 % w/w.
  • the composition further comprises more than one (e.g. a mixture of two, three or four) adhesion promoters.
  • the composition includes a single adhesion promoter.
  • the nail composition may include that adhesion promoter as the sole adhesion promoter or as one of a plurality of adhesion promoters.
  • the adhesion promoter is Gamma- Glycidoxylpropyltrimethoxysilane (Silquest A-187).
  • the adhesion promoter is 1,2,4,5-benzenetetracarboxylicacid,1,4-bis[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-1-[[(2-methyl-1-oxo-2-propen-1-yl)oxy]methyl]ethyl]ester which is known in the art as pyromellitic glycerol dimethacrylate.
  • the adhesion promoter is acrylic acid.
  • the adhesion promoter is methacrylic acid.
  • the adhesion promoter is 2-(methacryloyloxy)ethyl acetoacetate.
  • the additional adhesion promoter is mono-2-(methacryloyloxy)ethyl succinate.
  • the invention provides a method of applying a composition of the disclosure to a nail comprising contacting the nail with the composition.
  • the composition is applied directly to the nail and not through a so-called "prebond” or "tie” layer.
  • prebond or tie layer
  • tie layer is used.
  • the nail composition of the present invention can be applied to the nail by any conventional apparatus, such as by dipping a nail polish brush into the composition and painting it onto the nail. It is an optional feature of the methods of the invention that only a single coating of the composition is applied.
  • the nail is then exposed to radiation.
  • the nail is exposed to radiation for a period of time of up to about 5 minutes, optionally up to about 4 minutes, for example up to about 3 minutes and for example up to about 2 minutes, e.g. less than one minute.
  • the nail may then be exposed to radiation for a period of time of from about 30 seconds to about 5 minutes, optionally from about 1 minute to about 5 minutes, optionally from about 1 minute to about 4 minutes, for example about 1 minute to about 3 minutes and for example from about 1 minute to about 2 minutes.
  • the nail may then be exposed to radiation for a period of time of up to about one minute.
  • the radiation comprises or is sunlight.
  • the radiation comprises or is UV radiation from an electrical radiation source.
  • a commercially available UV radiation source or lamp will be suitable for the methods of the present invention.
  • the radiation is emitted from an LED array.
  • the radiation to which the nail composition is exposed has a wavelength of from about 200 nm to about 760 nm. In an embodiment, the radiation to which the nail composition is exposed has a wavelength of from about 200 nm to about 450 nm. In an embodiment, the radiation to which the nail composition is exposed has a wavelength of from about 310 nm to about 425 nm, e.g. about 315 to about 380 nm. In an embodiment, the radiation to which the nail composition is exposed has a wavelength of from about 400 nm to about 450 nm.
  • the intensity of the radiation is normally measured at a particular wavelength.
  • the conventional wavelength at which the intensity of light is measured is 365 nm.
  • the intensity of the radiation to which the nail composition is exposed has an intensity of from about 0.5 to about 2 mW/cm 2 at about 365 nm. This intensity range is generally regarded in the art as being "low intensity".
  • the intensity is from about 0.7 to about 1.2 mW/cm 2 at 365 nm.
  • the intensity is may be about 0.9 mW/cm 2 at 365 nm or 1.5 mW/cm 2 at 365 nm.
  • the intensity of the radiation is measured across all wavelengths.
  • the intensity of radiation is from about 0.1 mW/cm 2 to about 100 mW/cm 2 .
  • a device such as a UV Power Puck can be used. This kind of device is an electro-optic radiometer that measures and displays the total UV energy and UV intensity.
  • the UV Power Puck measures four different ranges of ultraviolet wavelengths at the same time (i.e. UVA (320-390nm), UVB (280-320nm), UVC (250-260nm) and UVV (395-445nm).
  • the total intensity of the radiation is from about 5 to about 50 mW/cm 2 .
  • the nail coating composition of the invention typically has been exposed to UV radiation and has cured, it is not necessary to carry out a further step of wiping uncured nail composition from the outer surface of the coated nail.
  • the outer surface is substantially tack-free after curing with UV radiation. This is a benefit of the coating compositions of the invention over the prior art compositions.
  • the cured nail varnish composition may conveniently be removed by using a conventional nail polish remover (e.g. acetone).
  • the nail polish remover and the cured nail varnish composition are suitably maintained in contact for about 1 minute to about 10 minutes. It is thought that contacting the cured composition with the nail polish remover breaks down the cross-linked network.
  • the cured nail composition can be wipe off the nail in the same manner that a conventional solvent-based (i.e. non-UV curable composition) can be removed from a nail. It is not necessary to use abrasion to remove the cured nail composition of the present invention as is necessary with other conventional UV curable nail polish compositions.
  • the following examples provide various formulations falling within the scope of the present invention.
  • the resulting formulations have a viscosity in the desired range of 500 - 2000 cPs, are cured after only 2 minutes exposure to UV light, have the desired property of being smooth, dry and well adhered to the nail, soak off very easily when it is desired to remove the nail composition and have good stability.
  • each of the formulations was tested to determine whether the nail composition has the required properties of good adhesion, good stability and good durability. All of the following formulations were found to have these properties. Additionally, when the coated nails were soaked in acetone, the nail polish was easily removed without requiring abrasion.
  • the uncured coating is applied to a glass slide in a thin layer and cured for 2 minutes under a standard 36W UV lamp.
  • the adhesion of the cured coating is then tested using a method described by Schlossman et al, J. Soc. Cosmet. Chem. 32, 43-52 (January/February 1981 ) called the "cellophane adhesion test".
  • the coating is deeply scribed with a razor blade in the shape of a Greek letter lambda and a hash sign. This cut is made 1 inch (about 2.5 cm) high and 1/2 inch (about 1.25 cm) wide at the base. A piece of ordinary % inch (about 1.9 cm) cellophane is laid over its entire surface with a hard rubber eraser. A tab large enough to be grasped firmly with the fingers is left well above the figure. The tape is then removed by pulling rapidly and evenly toward the bottom of the test panel.
  • the squares of coating that are removed are counted and an estimate of the amount of coating removed is given. All of the formulations have a percentage of coating removed of less than 10 %.
  • a conventional solvent based nail polish was tested using the same procedure.
  • the uncured coating is applied to a glass slide in a thin layer and left to dry for 24 hours at room temperature. This period of time is much longer than conventional nail polish would be left to dry when applying it to a nail.
  • the adhesion of the cured coating is then tested using the "cellophane adhesion test" as described above.
  • the conventional solvent based nail polishes have a percentage coating removed of between 30 and 100 % depending on the brand tested. Thus, the nail polishes of the present invention have much better adhesive properties than conventional nail polishes.
  • the stability of the formulations is then tested. This is done to mimic the shelf life of the formulation in the bottle.
  • the coating is placed in a nail polish bottle with brush and put into ovens at two different temperatures.
  • the uncured product has to remain mobile and usable for >5 days at 55°C and >6 hours at 82°C.
  • the shelf life in the bottle will be at least one year. A shelf life of this length means that the formulation is commercially viable.
  • Genomer 03-956 - Rahn Aliphatic urethane Dimethacrylate Monomer free for radically curable inks, coatings and adhesives.
  • Data Sheet dated March 2007 Specific Gravity: 1.1 - 1.2; Viscosity: 10 - 200 cPs (15% solids in NH4OH solution) ; Particle size: 60 - 100 (% thru 6 mesh) 4.6 Genomer 09-293 - Rahn Aliphatic urethane acrylate ; Monomer free for radically curable inks, coatings and adhesives.
  • Genomer 03-956 - Rahn Aliphatic urethane Dimethacrylate Monomer free for radically curable inks, coatings and adhesives.
  • Genomer 09-293 - Rahn Aliphatic urethane acrylate Monomer free for radically curable inks, coatings and adhesives.
  • Genomer 03-956 - Rahn Aliphatic urethane Dimethacrylate Monomer free for radically curable inks, coatings and adhesives.
  • Data Sheet dated March 2007 Specific Gravity: 1.1 - 1.2; Viscosity: 10 - 200 cPs (15% solids in NH4OH solution); Particle size: 60 - 100 (% thru 6 mesh) 5.1
  • Genomer 09-293 - Rahn Aliphatic urethane acrylate Monomer free for radically curable inks, coatings and adhesives.
  • composition of this example is the same as the compostion of example 7, except that the composition of example 7 has a trifunctional thiol level of 16.4% whereas the composition of this example has a reduced level of trifunctional thiol (11.0%).
  • the level of Genomer 03-956 and isobornyl methacrylate were increased by 1.5 and 3.9% respectively to retain the same formulation weight.
  • the composition of example 7 demonstrates the desired dry to touch properties, the composition of this example is slightly tacky after curing (which is not desireable).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Claims (23)

  1. Packung, umfassend:
    (i) eine Nagelbeschichtungszusammensetzung, umfassend:
    eine strahlungshärtbare Komponente, umfassend ein acrylatterminiertes Oligomer in Kombination mit zumindest einem Acrylatmonomer; wobei der Begriff "Acrylat" Verbindungen beinhaltet, die den Teil CH2=CHCOO- oder CH2=C(CH3)COO- aufweisen; und wobei das acrylatterminierte Oligomer ein Urethan-Rückgrat beinhaltet; und
    eine Thiolkomponente, die in einer Menge von 5 Gew.-% bis 90 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist, wobei die Thiolkomponente eine Verbindung umfasst, die zwei oder mehr SH-Gruppen enthält, wobei, wenn die Thiolkomponente aus einem bis- und/oder tris-funktionellen Thiol besteht, sie zumindest als 15 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist; und wobei, wenn das Thiol ein tetra- oder höher funktionelles Thiol ist, es zumindest als 10 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist; und
    (ii) ein Mittel zum Auftragen der Nagelbeschichtungszusammensetzung auf einen Nagel.
  2. Packung, umfassend:
    (i) eine Nagelbeschichtungszusammensetzung, umfassend:
    eine strahlungshärtbare Komponente, umfassend ein alyllterminiertes Oligomer in Kombination mit zumindest einem Acrylatmonomer und/oder zumindest einem acrylatterminierten Oligomer; wobei der Begriff "Acrylat" Verbindungen beinhaltet, die den Teil CH2=CHCOO- oder CH2=C(CH3)COO- aufweisen; und wobei das acrylatterminierte Oligomer und/oder das allylterminierte Oligomer ein Urethan-Rückgrat beinhaltet; und
    eine Thiolkomponente, die in einer Menge von 5 Gew.-% bis 90 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist, wobei die Thiolkomponente eine Verbindung umfasst, die zwei oder mehr SH-Gruppen enthält, wobei, wenn die Thiolkomponente aus einem bis- und/oder tris-funktionellen Thiol besteht, sie zumindest als 15 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist; und wobei, wenn das Thiol ein tetra- oder höher funktionelles Thiol ist, es zumindest als 10 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist; und
    (ii) ein Mittel zum Auftragen der Nagelbeschichtungszusammensetzung auf einen Nagel.
  3. Packung nach Anspruch 1 oder Anspruch 2, wobei die Zusammensetzung härtbar ist, indem sie Strahlung mit einer Wellenlänge von 200 nm bis 450 nm ausgesetzt wird.
  4. Packung nach einem vorhergehenden Anspruch, wobei das Thiol in einer Menge von bis zu ungefähr 50 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist.
  5. Packung nach einem vorhergehenden Anspruch, wobei das Thiol eine allgemeine Struktur
    Figure imgb0052
     aufweist, wobei
    R1, R2, R3 und R4 jeweils unabhängig aus der Gruppe ausgewählt sind, die aus H und einem Substituenten besteht;
    R5 -CR6aR6bR6c ist;
    wobei R6a
    Figure imgb0053
     ist, R6b und R6c jeweils unabhängig aus der Gruppe ausgewählt sind, die aus
    Folgendem besteht: H, C1-6-Alkyl und
    Figure imgb0054
    k eine ganze Zahl von 0 bis 10 ist; und
    m und n jeweils unabhängig eine ganze Zahl von 1 bis 10 sind.
  6. Packung nach Anspruch 5, wobei k 0 ist; und/oder wobei m eine ganze Zahl von 1 bis 3 ist; und/oder wobei n eine ganze Zahl von 1 bis 3 ist; und/oder wobei R1, R2, R3 und R4 jeweils unabhängig aus der Gruppe ausgewählt sind, die aus Folgendem besteht: H und C1-6-Alkyl.
  7. Packung nach einem der Ansprüche 5 bis 6, wobei R6b H ist.
  8. Packung nach einem der Ansprüche 5 bis 6, wobei R6b
    Figure imgb0055
     ist.
  9. Packung nach einem der Ansprüche 5 bis 8, wobei R6c H ist.
  10. Packung nach einem der Ansprüche 5 bis 8, wobei R6c
    Figure imgb0056
     ist.
  11. Packung nach einem der Ansprüche 5 bis 8, wobei R6c C1-6-Alkyl ist.
  12. Packung nach einem der Ansprüche 1 bis 4, wobei die Thiolverbindung aus der Gruppe ausgewählt ist, die aus Folgendem besteht:
    Figure imgb0057
    Figure imgb0058
     und
    Figure imgb0059
  13. Packung nach einem vorhergehenden Anspruch, wobei das acrylatterminierte Oligomer und/oder das allylterminierte Oligomer in einer Menge von 5 Gew.-% bis 90 Gew-% der Zusammensetzung vorhanden ist.
  14. Packung nach einem vorhergehenden Anspruch, wobei das acrylatterminierte Oligomer und/oder das allylterminierte Oligomer, wenn bei 25 °C gemessen, eine Viskosität von 2000 bis 150000 cPs aufweist.
  15. Packung nach einem vorhergehenden Anspruch, wobei die strahlungshärtbare Komponente Acrylsäureestermonomer umfasst; wobei das Acrylsäureestermonomer optional in einer Menge von bis zu 90 Gew.-% der Zusammensetzung vorhanden ist.
  16. Packung nach einem vorhergehenden Anspruch, wobei die strahlungshärtbare Komponente einen Photoinitiator umfasst; wobei der Photoinitiator optional in einer Menge von 0,1 Gew.-% bis 20 Gew.-% der Zusammensetzung vorhanden ist.
  17. Packung nach einem vorhergehenden Anspruch, ferner umfassend ein Verdickungsmittel in einer Menge von bis zu 10 Gew.-% der Zusammensetzung; und/oder
    ferner umfassend einen Stabilisator freier Radikale in einer Menge von bis zu 2 Gew.-% der Zusammensetzung.
  18. Packung nach einem vorhergehenden Anspruch, ferner umfassend einen Farbstoff und eine organische Flüssigkeit; wobei
    der Farbstoff optional in einer Menge von 20 Gew.-% bis 80 Gew.-% von kombiniertem Farbstoff und organischer Flüssigkeit vorhanden ist und der Farbstoff und die organische Flüssigkeit zusammen bis zu 10 Gew.-% der Zusammensetzung ergeben; wobei
    der Farbstoff optional ein Pigment ist; wobei
    die organische Flüssigkeit optional ein Öl ist; und wobei ferner
    das Öl optional aus der Gruppe ausgewählt ist, die aus Folgendem besteht: Rizinusöl, dehydriertem Rizinusöl, Baumwollsamenöl, Fischöl, Leinsamenöl, Menhadenöl, Oiticiaöl, Palmkernöl, Perillaöl, Safloröl, Sardinenöl, Sojaöl und Tungöl.
  19. Packung nach einem vorhergehenden Anspruch, ferner umfassend bis zu 2 Gew.-% eines Chelatbildners.
  20. Verfahren zum Auftragen der Nagelzusammensetzung nach einem der Ansprüche 1 bis 19 auf einen Nagel, wobei das Verfahren Folgendes umfasst:
    (a) Kontaktieren des Nagels mit der Zusammensetzung; und
    (b) Aussetzen der Zusammensetzung gegenüber Strahlung, um die Zusammensetzung zu härten.
  21. Verfahren nach Anspruch 20, wobei die Zusammensetzung über einen Zeitraum von 1 Minute bis 5 Minuten ausgesetzt wird; und/oder
    wobei die Strahlung Sonnenlicht ist; und/oder
    wobei die Strahlung Strahlung ist, die von einer Strahlungsquelle erzeugt wird, die eine Wellenlänge von 200 nm bis 760 nm und eine Strahlungsintensität von 0,1 mW/cm2 bis 100 mW/cm2 aufweist; und/oder wobei eine einzelne Deckschicht der Zusammensetzung auf den Nagel aufgetragen wird.
  22. Verwendung einer Thiolverbindung, um einer Nagelbeschichtungszusammensetzung Dry-to-Touch-Eigenschaften zu verleihen, wobei die Nagelbeschichtungszusammensetzung eine strahlungshärtbare Komponente umfasst, umfassend ein acrylatterminiertes Oligomer in Kombination mit zumindest einem Acrylatmonomer; und eine Thiolkomponente, die in einer Menge von 5 Gew.-% bis 90 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist, wobei die Thiolkomponente eine Verbindung umfasst, die zwei oder mehr SH-Gruppen enthält, wobei, wenn die Thiolkomponente aus einem bis- und/oder tris-funktionellen Thiol besteht, sie zumindest als 15 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist und wobei, wenn das Thiol ein tetra- oder höher funktionelles Thiol ist, es zumindest als 10 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist.
  23. Verwendung einer Thiolverbindung, um einer Nagelbeschichtungszusammensetzung Dry-to-Touch-Eigenschaften zu verleihen, wobei die Nagelbeschichtungszusammensetzung Folgendes umfasst: eine strahlungshärtbare Komponente, umfassend ein allylterminiertes Oligomer in Kombination mit zumindest einem Acrylatmonomer und/oder zumindest einem acrylatterminierten Oligomer; und eine Thiolkomponente, die in einer Menge von 5 Gew.-% bis 90 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist, wobei die Thiolkomponente eine Verbindung umfasst, die zwei oder mehr SH-Gruppen enthält, wobei, wenn die Thiolkomponente aus einem bis- und/oder tris-funktionellen Thiol besteht, sie zumindest als 15 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist; und wobei, wenn das Thiol ein tetra- oder höher funktionelles Thiol ist, es zumindest als 10 Gew.-% der Nagelbeschichtungszusammensetzung vorhanden ist.
EP12791844.9A 2011-11-24 2012-11-26 Nagellackzusammensetzung Active EP2782552B8 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1120334.6A GB201120334D0 (en) 2011-11-24 2011-11-24 Nail polish
US201161564573P 2011-11-29 2011-11-29
US201261601457P 2012-02-21 2012-02-21
PCT/GB2012/052915 WO2013076511A2 (en) 2011-11-24 2012-11-26 Nail polish

Publications (3)

Publication Number Publication Date
EP2782552A2 EP2782552A2 (de) 2014-10-01
EP2782552B1 true EP2782552B1 (de) 2018-09-05
EP2782552B8 EP2782552B8 (de) 2018-10-17

Family

ID=45475702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12791844.9A Active EP2782552B8 (de) 2011-11-24 2012-11-26 Nagellackzusammensetzung

Country Status (6)

Country Link
US (1) US9623268B2 (de)
EP (1) EP2782552B8 (de)
JP (1) JP2014533716A (de)
CN (1) CN104066420A (de)
GB (2) GB201120334D0 (de)
WO (1) WO2013076511A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013208304A1 (en) * 2012-01-09 2014-07-24 Revlon Nail enamel composition
KR101508734B1 (ko) 2013-07-15 2015-04-07 이광수 광 및 온도에 따라 변색되는 자외선 경화형 매니큐어
GB201317635D0 (en) * 2013-10-04 2013-11-20 Verdex Ltd Cationically UV curable nail coating compositions and methods of using same
WO2015061485A1 (en) * 2013-10-23 2015-04-30 Creative Nail Design, Inc. Nail coatings including fatty acid esters
US9044383B1 (en) 2013-10-25 2015-06-02 Anthony Weiburg Compounds and methods for drug delivery via a human nail
FR3013975B1 (fr) * 2013-12-04 2015-11-20 Oreal Compositions de vernis photoreticulables et procedes d'application
FR3013963B1 (fr) * 2013-12-04 2016-12-23 Oreal Compositions de vernis photoreticulables a titre de revetement de base et procedes d'application
FR3013976B1 (fr) * 2013-12-04 2015-12-11 Oreal Compositions de vernis photoreticulables a titre de revetement de base et procedes d'application
FR3013969B1 (fr) * 2013-12-04 2018-01-26 Oreal Compositions de vernis photoreticulables a titre de revetement de base et procedes d'application
US20150190331A1 (en) * 2014-01-09 2015-07-09 Pakaly Enterprise Co., Ltd. Nail lacquer composition with hyposensitivity
FR3036958B1 (fr) * 2015-06-04 2018-10-12 Fiabila Composition de vernis a ongles a sechage physique, son procede d'application et kit comprenant une telle composition
US10449141B2 (en) * 2015-08-29 2019-10-22 Lijuan Zhen Gel nail polish and its manufacturing and using method
KR101770985B1 (ko) 2016-03-23 2017-08-24 주식회사 티에이치엘 수성 매니큐어 조성물 및 이의 제조방법
TWI595890B (zh) * 2016-05-09 2017-08-21 穗曄實業股份有限公司 光固化甲油膠組成物
JP6755544B2 (ja) * 2016-05-27 2020-09-16 株式会社サクラクレパス 光硬化性人工爪組成物
JP6841485B2 (ja) * 2016-08-12 2021-03-10 株式会社サクラクレパス 重合禁止剤含有ウレタン（メタ）アクリレートオリゴマー光硬化性人工爪組成物
JP6892108B2 (ja) * 2017-03-23 2021-06-18 株式会社サクラクレパス 光硬化性人工爪組成物
DE102017004546B4 (de) * 2017-05-12 2022-01-05 L/N Health And Beauty Aps Kit zur Nagelkorrektur
JP6996828B2 (ja) * 2017-06-22 2022-01-17 株式会社松風 光硬化性人工爪組成物
EP3707181A4 (de) * 2017-10-31 2021-08-11 Arkema France Härtbare zusammensetzungen mit thiolverbindungen
US11739177B2 (en) 2018-04-20 2023-08-29 Adaptive 3D Technologies Sealed isocyanates
WO2019204770A1 (en) 2018-04-20 2019-10-24 Lund Benjamin R Sealed isocyanates
US20200078288A1 (en) * 2018-09-07 2020-03-12 Eastern Michigan University Biobased, uv-curable nail polish compositions and related methods
US11911956B2 (en) 2018-11-21 2024-02-27 Adaptive 3D Technologies Using occluding fluids to augment additive manufacturing processes
EP3808787A1 (de) * 2019-10-16 2021-04-21 Margarita Zimmer Lichthärtbare klebstoffzusammensetzung für die wimpernverlängerung
CN111035575A (zh) * 2019-12-16 2020-04-21 山东益丰生化环保股份有限公司 一种uv固化改性硫醇树脂指甲油及其制备方法
KR102350649B1 (ko) * 2020-02-20 2022-01-12 충북대학교 산학협력단 산분해 특성이 향상된 uv 경화형 젤 네일 폴리쉬 조성물 및 이의 용도
EP4227330A4 (de) * 2020-10-08 2024-10-09 DIC Corporation Harzzusammensetzung für stereolithographie
US20220395449A1 (en) * 2021-06-04 2022-12-15 Lilaque, Inc. Bio-gel composition and nail care system
JP7327863B1 (ja) * 2023-04-04 2023-08-16 株式会社サクラクレパス 硬化性人工爪組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896014A (en) * 1973-06-14 1975-07-22 Clairol Inc UV Curable polyene-polythiol-surfactant compositions
US3928113A (en) 1973-06-14 1975-12-23 Clairol Inc Method for coating human nails
US4234676A (en) 1978-01-23 1980-11-18 W. R. Grace & Co. Polythiol effect curable polymeric composition
US5130551A (en) 1989-08-15 1992-07-14 Ultraset Limited Partnership Nail drying apparatus
US5922334A (en) 1998-05-06 1999-07-13 Rohm And Haas Company Aqueous nail coating composition
US6803394B2 (en) * 1999-12-17 2004-10-12 Gel Products, Inc. Radiation curable nail coatings and artificial nail tips and methods of using same
JP3889430B2 (ja) 2003-10-01 2007-03-07 アサヌマ コーポレーション株式会社 ネイルエナメル用水性分散体および水性ネイルエナメル組成物
GB2452566A (en) * 2007-09-08 2009-03-11 Chemence Ltd A radiation curable, nail coating composition
JP5240939B2 (ja) * 2009-07-16 2013-07-17 十条ケミカル株式会社 光硬化型マニキュア組成物およびマニキュア方法
US20110256079A1 (en) 2010-04-14 2011-10-20 Mycone Dental Corporation Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US9623268B2 (en) 2017-04-18
EP2782552A2 (de) 2014-10-01
WO2013076511A3 (en) 2014-01-09
JP2014533716A (ja) 2014-12-15
GB2496990B (en) 2014-10-01
GB201120334D0 (en) 2012-01-04
US20130146077A1 (en) 2013-06-13
GB201221173D0 (en) 2013-01-09
CN104066420A (zh) 2014-09-24
GB2496990A (en) 2013-05-29
WO2013076511A2 (en) 2013-05-30
EP2782552B8 (de) 2018-10-17

Similar Documents

Publication Publication Date Title
EP2782552B1 (de) Nagellackzusammensetzung
JP5475067B2 (ja) 人工爪原料組成物、人工爪原料組成物の硬化方法、人工爪の製造方法および人工爪
KR101700010B1 (ko) 저 감작성을 갖는 손톱래커 조성물
CN102770119B (zh) 指甲或人工指甲被覆用硬化性树脂组合物
CN105878054B (zh) Led-uv光疗胶免擦洗封层胶及其制备方法
TWI595890B (zh) 光固化甲油膠組成物
JP7058856B2 (ja) 粘着付与剤含有光硬化性人工爪組成物
EP3215115B1 (de) Systeme und verfahren für entfernbare beschichtung
WO2011016531A1 (ja) 爪装飾用硬化性組成物、爪装飾の形成方法、及び、爪装飾の除去方法
US20150224045A1 (en) Radiation curable nail preparations, post-processing nail finisher and methods of application
JPWO2014157271A1 (ja) 人工爪組成物、人工爪、人工爪の形成方法、人工爪の除去方法、及び、ネイルアートキット
JP2011229725A (ja) 爪装飾の形成方法およびその除去方法、並びに、爪装飾および爪装飾用キット
JP2017210457A (ja) 疎水性ウレタン（メタ）アクリレートオリゴマー含有自爪塗布用光硬化性人工爪組成物
JP6656662B1 (ja) 人工爪原料組成物、人工爪原料組成物の硬化方法、人工爪の製造方法および人工爪
CN110638689A (zh) 一种新型的指甲油
JP2018070498A (ja) セピオライト含有光硬化性人工爪組成物
CN110025504B (zh) 光固化性指甲化妆材料
JP2022111991A (ja) 光硬化性人工爪組成物
JP6841485B2 (ja) 重合禁止剤含有ウレタン（メタ）アクリレートオリゴマー光硬化性人工爪組成物
JP2019530680A (ja) 爪化粧用組成物、その使用方法および爪化粧用樹脂
CA3009320A1 (en) Methods and compositions for readily removing nail coatings
JP2017210456A (ja) 光硬化性人工爪組成物
WO2016194730A1 (ja) 爪化粧料及びネイルアートキット
FR2999424A1 (fr) Composition aqueuse pour manucure du type enlevable
US20170312793A1 (en) Uv-uvv curable, wear-resistant nail polish

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140619

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

17Q First examination report despatched

Effective date: 20160226

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/87 20060101ALI20180308BHEP

Ipc: A61Q 3/02 20060101ALI20180308BHEP

Ipc: A61K 8/46 20060101ALI20180308BHEP

Ipc: A61K 8/85 20060101ALI20180308BHEP

Ipc: A61K 8/37 20060101AFI20180308BHEP

Ipc: A61K 8/81 20060101ALI20180308BHEP

INTG Intention to grant announced

Effective date: 20180327

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1036995

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180915

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG B8

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012050720

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180905

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181205

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181206

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181205

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1036995

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190105

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190105

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012050720

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181126

26N No opposition filed

Effective date: 20190606

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20181130

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20121126

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180905

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180905

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20241120

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20241105

Year of fee payment: 13